Mirum ' s Oral Drug Becomes First US-Approved Alagille Syndrome Therapy Mirum ' s Oral Drug Becomes First US-Approved Alagille Syndrome Therapy

Mirum Pharmaceuticals said its drug became the first US-approved therapy for treating itching in patients with rare liver disorder Alagille syndrome and would be available for distribution immediately.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news